Inactive

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has negotiated an other than full and open competition basis with Technical Resources Inter... The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) has negotiated an other than full and open competition basis with Technical Resources International Inc. (TRI) to acquire training and transition services in support of a currently ongoing service. TRI is currently providing regulatory support through Purchase Order (PO) #75N93019P01252 for IND Submission Support Services including the eCTD solution that is integrated with VRC RSSP program needs which meet the requirements and complexities of VRC RSSP. The current eCTD application Liquent that was provided by NIAID Office of Cyber Infrastructure and Computational Biology (OCICB) will be transitioned over to a new eCTD system. Liquent will stop supporting the on-premise version of their software summer of 2022 and Lorenz’s expected production deployment of DocuBridge is June 30, 2022. RSSP cannot have a stoppage of the eCTD system therefore the transition must occur as planned. TRI’s service is required to continue the IND support, and TRI must be trained in Lorenz DocuBridge, the new eCTD application in order to provide continued support for the IND PO. Transition support from TRI for this new eCTD software is out of the scope for current purchase order, so this current new acquisition is needed to help train and transition TRI to the new system. This new acquisition is essentially follow on services that is crucial for and supports TRI’s currently existing and ongoing services. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. This is a post-award notice/justification that the PO has been awarded to TRI.